NorthRock Partners’s Azora Therapeutics AZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-16
Closed -$43K – 338
2021
Q3
$43K Buy
+16
New +$33.5K ﹤0.01% 279

Other funds holding AZR

NorthRock Partners's AZR Position: Q4 2021 in Review

NorthRock Partners sold out of Azora Therapeutics (AZR) in Q4 2021, closing a stake of 16 shares — an estimated $43K sold.

NorthRock Partners first reported a position in AZR in Q3 2021 and held it in 1 quarter. The position peaked at $43K in Q3 2021. 23 funds tracked by Wall St. Rank hold AZR as of Q4 2021.

  • NorthRock Partners reported no remaining Azora Therapeutics position as of Q4 2021 after selling out during the quarter.
  • NorthRock Partners sold 16 Azora Therapeutics shares in Q4 2021, an estimated $43K.
  • NorthRock Partners first reported a position in Azora Therapeutics in Q3 2021 and held it in 1 quarter.
  • NorthRock Partners's Azora Therapeutics position peaked at $43K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Azora Therapeutics as of Q4 2021.

Based on NorthRock Partners's 13F filing for Q4 2021, filed 7 Feb 2022.